Dengue 4 in Ceará, Brazil: characterisation of epidemiological and laboratorial aspects and causes of death during the first epidemic in the state
Mem. Inst. Oswaldo Cruz
;
113(11): e180320, 2018. tab, graf
Article
Dans Anglais
| LILACS
| ID: biblio-976230
ABSTRACT
BACKGROUND The first dengue cases in Brazil with laboratory confirmation occurred in the northern region of the country, with the isolation of two serotypes, dengue virus 1 (DENV-1) and DENV-4. In Ceará, the introduction of DENV-4 was reported during a DENV-1 epidemic in 2011, with only two isolations. OBJECTIVES The aim of this study was to characterise the first DENV-4 epidemic in the state of Ceará, Brazil. METHODS The study population was composed of patients with suspected dengue that were reported to health care units from January to December 2012. The laboratory confirmation of infection was made by viral isolation, reverse transcription polymerase chain reaction (RT-PCR), AgNS1, immunohistochemistry and IgM enzyme-linked immunosorbent assay (ELISA). MAIN CONCLUSIONS In the study year, 72,211 suspected dengue cases were reported and 51,865 of these cases (71.8%) were confirmed to be positive. Co-circulation of three serotypes, DENV-1, DENV-3 and DENV-4, was detected with a predominance of DENV-4 (95.3%). Most cases were not severe, but there were 44 fatal outcomes. DENV-4 Genotype II was identified for the first time in Ceará.
Texte intégral:
Disponible
Indice:
LILAS (Amériques)
Sujet Principal:
Cause de décès
/
Dengue
Type d'étude:
Etude d'étiologie
Pays comme sujet:
Amérique du Sud
/
Brésil
langue:
Anglais
Texte intégral:
Mem. Inst. Oswaldo Cruz
Thème du journal:
Médecine tropicale
/
Parasitologie
Année:
2018
Type:
Article
Pays d'affiliation:
Brésil
Institution/Pays d'affiliation:
Centro Universitário Christus/BR
/
Instituto Oswaldo Cruz-Fiocruz/BR
/
Instituto de Prevenção de Câncer/BR
/
Laboratório Central de Saúde Pública/BR
/
Secretaria de Saúde do Estado do Ceará/BR
/
Universidade Estadual do Ceará/BR
/
Universidade Federal do Ceará/BR
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS